About Safe Medical Evaluation

Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.

Investment Details

Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Biotechnology, AI/ML, Education (+3 more)
Investor Type
Venture Capital

Investment Focus

Focus Areas
AI/ML Education Enterprise Healthcare VR/AR +2 more
Investment Stages
Early Stage Venture